{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:17:17Z","timestamp":1793236637887,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005389","name":"Universit\u00e0 degli Studi dell'Insubria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastric neuroendocrine neoplasms (gNENs) encompass all the spectrum of NENs including neuroendocrine carcinomas (gNECs), mixed neuroendocrine\/non-neuroendocrine neoplasms (gMiNENs) and neuroendocrine tumors (gNETs). Differently from other digestive sites, gNETs are subclassified according to the clinicopathologic setting in which they arise, with important prognostic implications. Since gastric endoscopic biopsies represent a high-volume daily activity in both referral and community hospitals, pathologists should be increasingly aware of this disease. This will allow to correctly identify the different entities and, when present, their precursor lesions, giving useful information to clinicians for the best patient management. This review paper aims to provide morphologic, immunophenotypic, and, when necessary, molecular criteria for the correct diagnosis and subtyping of gNENs. In addition, a simplified prognostic classification schema of enterochromaffin-like (ECL)-cell NETs is proposed, based on gastrin serum levels and the status of gastric acid secretion.<\/jats:p>","DOI":"10.1007\/s00428-025-04340-x","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T08:23:37Z","timestamp":1763799817000},"page":"79-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neuroendocrine neoplasms of the stomach. Update on diagnostic criteria, classification, and prognostic markers"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-7295","authenticated-orcid":false,"given":"Silvia","family":"Uccella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-2403","authenticated-orcid":false,"given":"Stefano","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"4340_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jclinpath-2014-202515","volume":"67","author":"S La Rosa","year":"2014","unstructured":"La Rosa S, Vanoli A (2014) Gastric neuroendocrine neoplasms and related precursor lesions. J Clin Pathol 67:938\u2013948. https:\/\/doi.org\/10.1136\/jclinpath-2014-202515","journal-title":"J Clin Pathol"},{"key":"4340_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335\u20131342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"4340_CR3","doi-asserted-by":"publisher","first-page":"9454","DOI":"10.1002\/cam4.3524","volume":"9","author":"H Alwan","year":"2020","unstructured":"Alwan H, La Rosa S, Andreas Kopp P, Germann S, Maspoli-Conconi M, Sempoux C, Bulliard JL (2020) Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland. Cancer Med 9:9454\u20139461","journal-title":"Cancer Med"},{"key":"4340_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13473","volume":"37","author":"M Maly","year":"2025","unstructured":"Maly M, Callebout E, Ribeiro S, Hoorens A, Carton S, Cuyle PJ, Vandamme T, Borbath I, Demetter P, Van Damme N, Van Eycken L, Verslype C, Geboes K (2025) Neuroendocrine tumors in the stomach: an epidemiological analysis of Belgian Cancer Registry data 2010\u20132019. J Neuroendocrinol 37:e13473. https:\/\/doi.org\/10.1111\/jne.13473","journal-title":"J Neuroendocrinol"},{"key":"4340_CR5","unstructured":"Klimstra DS KG, La Rosa S, Rindi G (2019) Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours Editorial Board. Digestive system tumours. 5th edn. International Agency for Research on Cancer, Lyon, pp 16\u201319"},{"key":"4340_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12020-017-1355-9","volume":"57","author":"S Manfredi","year":"2017","unstructured":"Manfredi S, Walter T, Baudin E, Coriat R, Ruszniewski P, Lecomte T, Laurenty AP, Goichot B, Rohmer V, Roquin G, Cojocarasu OZ, Lombard-Bohas C, Lepage C, Morcet J, Cadiot G (2017) Management of gastric neuro-endocrine tumours in a large French national cohort (GTE). Endocrine 57:504\u2013511. https:\/\/doi.org\/10.1007\/s12020-017-1355-9","journal-title":"Endocrine"},{"key":"4340_CR7","doi-asserted-by":"publisher","first-page":"104577","DOI":"10.5306\/wjco.v16.i5.104577","volume":"16","author":"G Christodoulidis","year":"2025","unstructured":"Christodoulidis G, Kouliou MN, Ragias D, Chatziisaak D, Agko ES, Schizas D, Zacharoulis D (2025) Last decade of advances in gastric neuroendocrine tumors: innovations, challenges, and future directions. World J Clin Oncol 16:104577. https:\/\/doi.org\/10.5306\/wjco.v16.i5.104577","journal-title":"World J Clin Oncol"},{"key":"4340_CR8","first-page":"223","volume":"42","author":"E Solcia","year":"1975","unstructured":"Solcia E, Capella C, Vassallo G, Buffa R (1975) Endocrine cells of the gastric mucosa. Int Rev Cyto 42:223\u2013286","journal-title":"Int Rev Cyto"},{"key":"4340_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.24750","volume":"4","author":"Z Xu","year":"2021","unstructured":"Xu Z, Wang L, Dai S, Chen M, Li F, Sun J, Luo F (2021) Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States. JAMA Netw Open 4:e2124750. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.24750","journal-title":"JAMA Netw Open"},{"key":"4340_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100098","volume":"36","author":"JC Poveda","year":"2023","unstructured":"Poveda JC, Chahar S, Garcia-Buitrago MT, Montgomery EA, McDonald OG (2023) The morphologic spectrum of gastric type 1 enterochromaffin-like cell neuroendocrine tumors. Mod Pathol 36:100098. https:\/\/doi.org\/10.1016\/j.modpat.2023.100098","journal-title":"Mod Pathol"},{"key":"4340_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/pin.70022","volume":"75","author":"T Norose","year":"2025","unstructured":"Norose T, Ohike N, Tsukada M, Sugiura Y, Koizumi H, Nakamoto Y, Tateishi K, Mikami S, Koike J (2025) Gastric neuroendocrine tumor with pancreatic acinar cell differentiation in the background of atrophic gastritis: a possible variant of Type 1 ECL-cell NET- a case report. Pathol Int 75:359\u2013365. https:\/\/doi.org\/10.1111\/pin.70022","journal-title":"Pathol Int"},{"key":"4340_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-f","volume":"104","author":"G Rindi","year":"1993","unstructured":"Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E (1993) Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104:994\u20131006. https:\/\/doi.org\/10.1016\/0016-5085(93)90266-f","journal-title":"Gastroenterology"},{"key":"4340_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/his.14226","volume":"77","author":"S La Rosa","year":"2020","unstructured":"La Rosa S, Solcia E (2020) New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL-cell tumours related to hypergastrinaemia. Histopathology 77:862\u2013864. https:\/\/doi.org\/10.1111\/his.14226","journal-title":"Histopathology"},{"key":"4340_CR14","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.3748\/wjg.v25.i35.5376","volume":"25","author":"AV Tsolakis","year":"2019","unstructured":"Tsolakis AV, Ragkousi A, Vujasinovic M, Kaltsas G, Daskalakis K (2019) Gastric neuroendocrine neoplasms type 1: a systematic review and meta-analysis. World J Gastroenterol 25:5376\u20135387. https:\/\/doi.org\/10.3748\/wjg.v25.i35.5376","journal-title":"World J Gastroenterol"},{"key":"4340_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12022-016-9443-6","volume":"27","author":"HE Lee","year":"2016","unstructured":"Lee HE, Mounajjed T, Erickson LA, Wu TT (2016) Sporadic gastric well-differentiated neuroendocrine tumors have a higher Ki-67 proliferative index. Endocr Pathol 27:259\u2013267. https:\/\/doi.org\/10.1007\/s12022-016-9443-6","journal-title":"Endocr Pathol"},{"key":"4340_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000489902","volume":"107","author":"A Vanoli","year":"2018","unstructured":"Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E (2018) Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: analysis of 200 cases with extended follow-up. Neuroendocrinology 107:114\u2013126. https:\/\/doi.org\/10.1159\/000489902","journal-title":"Neuroendocrinology"},{"key":"4340_CR17","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.humpath.2013.02.005","volume":"44","author":"A Vanoli","year":"2013","unstructured":"Vanoli A, La Rosa S, Luinetti O, Klersy C, Manca R, Alvisi C, Rossi S, Trespi E, Zangrandi A, Sessa F, Capella C, Solcia E (2013) Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol 44:1827\u20131837. https:\/\/doi.org\/10.1016\/j.humpath.2013.02.005","journal-title":"Hum Pathol"},{"key":"4340_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/00365521.2016.1236397","volume":"52","author":"H Zhang","year":"2017","unstructured":"Zhang H, Jin Z, Cui R, Ding S, Huang Y, Zhou L (2017) Autoimmune metaplastic atrophic gastritis in Chinese: a study of 320 patients at a large tertiary medical center. Scand J Gastroenterol 52:150\u2013156. https:\/\/doi.org\/10.1080\/00365521.2016.1236397","journal-title":"Scand J Gastroenterol"},{"key":"4340_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12022-014-9315-x","volume":"25","author":"C Bordi","year":"2014","unstructured":"Bordi C (2014) Neuroendocrine pathology of the stomach: the Parma contribution. Endocr Pathol 25:171\u2013180. https:\/\/doi.org\/10.1007\/s12022-014-9315-x","journal-title":"Endocr Pathol"},{"key":"4340_CR20","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/s0016-5085(99)70495-6","volume":"116","author":"AD Higham","year":"1999","unstructured":"Higham AD, Bishop LA, Dimaline R, Blackmore CG, Dobbins AC, Varro A, Thompson DG, Dockray GJ (1999) Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology 116:1310\u20131318. https:\/\/doi.org\/10.1016\/s0016-5085(99)70495-6","journal-title":"Gastroenterology"},{"key":"4340_CR21","doi-asserted-by":"publisher","first-page":"108155892513489","DOI":"10.1177\/10815589251348926","volume":"3","author":"C Kalkan","year":"2025","unstructured":"Kalkan C, Acehan F, Atay A, Karatas A, Aksoy E, Kenarli K, Kalkan EA, Karakan T, Kekilli M, Cindoruk M, Soykan I (2025) Risk factors associated with adenocarcinoma development in gastric neuroendocrine tumors: a multicenter 10-year follow-up study. J Investig Med 3:10815589251348926. https:\/\/doi.org\/10.1177\/10815589251348926","journal-title":"J Investig Med"},{"key":"4340_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2025.102556","volume":"49","author":"Y Chen","year":"2025","unstructured":"Chen Y, Ji X, Zhao W, Lin J, Xie S, Xu J, Mao J (2025) A real-world study on the characteristics of autoimmune gastritis: a single-center retrospective cohort in China. Clin Res Hepatol Gastroenterol 49:102556. https:\/\/doi.org\/10.1016\/j.clinre.2025.102556","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4340_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100491","volume":"37","author":"V Angerilli","year":"2024","unstructured":"Angerilli V, Vanoli A, Celin G, Ceccon C, Gasparello J, Sabbadin M, De Lisi G, Paudice M, Lenti MV, Rovedatti L, Di Sabatino A, Bazzocchi F, Lonardi S, Savarino E, Luchini C, Parente P, Grillo F, Mastracci L, Fassan M (2024) Gastric carcinoma in autoimmune gastritis: a histopathologic and molecular study. Mod Pathol 37:100491. https:\/\/doi.org\/10.1016\/j.modpat.2024.100491","journal-title":"Mod Pathol"},{"key":"4340_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.humpath.2011.01.018","volume":"42","author":"S La Rosa","year":"2011","unstructured":"La Rosa S, Inzani F, Vanoli A, Klersy C, Dainese L, Rindi G, Capella C, Bordi C, Solcia E (2011) Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol 42:1373\u20131384. https:\/\/doi.org\/10.1016\/j.humpath.2011.01.018","journal-title":"Hum Pathol"},{"key":"4340_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1530\/ERC-18-0582","volume":"26","author":"S Felder","year":"2019","unstructured":"Felder S, Jann H, Arsenic R, Denecke T, Prasad V, Knappe-Drzikova B, Maasberg S, Wiedenmann B, Pavel M, Pascher A, Pape UF (2019) Gastric neuroendocrine neoplasias: manifestations and comparative outcomes. Endocr Relat Cancer 26:751\u2013763. https:\/\/doi.org\/10.1530\/ERC-18-0582","journal-title":"Endocr Relat Cancer"},{"key":"4340_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archsurg.136.1.49","volume":"136","author":"M Schindl","year":"2001","unstructured":"Schindl M, Kaserer K, Niederle B (2001) Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg 136:49\u201354. https:\/\/doi.org\/10.1001\/archsurg.136.1.49","journal-title":"Arch Surg"},{"key":"4340_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10120-004-0303-6","volume":"8","author":"O Hosokawa","year":"2005","unstructured":"Hosokawa O, Kaizaki Y, Hattori M, Douden K, Hayashi H, Morishita M, Ohta K (2005) Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis. Gastric Cancer 8:42\u201346. https:\/\/doi.org\/10.1007\/s10120-004-0303-6","journal-title":"Gastric Cancer"},{"key":"4340_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MEG.0b013e328350fae8","volume":"24","author":"MP Spampatti","year":"2012","unstructured":"Spampatti MP, Massironi S, Rossi RE, Conte D, Sciola V, Ciafardini C, Ferrero S, Lodi L, Peracchi M (2012) Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature. Eur J Gastroenterol Hepatol 24:589\u2013593. https:\/\/doi.org\/10.1097\/MEG.0b013e328350fae8","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4340_CR29","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1245\/s10434-009-0687-y","volume":"16","author":"RA Gladdy","year":"2009","unstructured":"Gladdy RA, Strong VE, Coit D, Allen PJ, Gerdes H, Shia J, Klimstra DS, Brennan MF, Tang LH (2009) Defining surgical indications for type I gastric carcinoid tumor. Ann Surg Oncol 16:3154\u20133160. https:\/\/doi.org\/10.1245\/s10434-009-0687-y","journal-title":"Ann Surg Oncol"},{"key":"4340_CR30","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.4251\/wjgo.v15.i8.1497","volume":"15","author":"HF Zhang","year":"2023","unstructured":"Zhang HF, Zheng Y, Wen X, Zhao J, Li J (2023) Gastric neuroendocrine tumors in a BRCA2 germline mutation carrier: a case report. World J Gastrointest Oncol 15:1497\u20131504. https:\/\/doi.org\/10.4251\/wjgo.v15.i8.1497","journal-title":"World J Gastrointest Oncol"},{"key":"4340_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0960-7404(03)00034-3","volume":"12","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M (2003) Carcinoid tumors of the stomach. Surg Oncol 12:153\u2013172. https:\/\/doi.org\/10.1016\/s0960-7404(03)00034-3","journal-title":"Surg Oncol"},{"key":"4340_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/gast.2002.34231","volume":"123","author":"PL Peghini","year":"2002","unstructured":"Peghini PL, Annibale B, Azzoni C, Milione M, Corleto VD, Gibril F, Venzon DJ, Delle Fave G, Bordi C, Jensen RT (2002) Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology 123:68\u201385. https:\/\/doi.org\/10.1053\/gast.2002.34231","journal-title":"Gastroenterology"},{"key":"4340_CR33","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1210\/jc.2007-2279","volume":"93","author":"MJ Berna","year":"2008","unstructured":"Berna MJ, Annibale B, Marignani M, Luong TV, Corleto V, Pace A, Ito T, Liewehr D, Venzon DJ, Delle Fave G, Bordi C, Jensen RT (2008) A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 93:1582\u20131591. https:\/\/doi.org\/10.1210\/jc.2007-2279","journal-title":"J Clin Endocrinol Metab"},{"key":"4340_CR34","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/s0016-5085(99)70174-5","volume":"116","author":"G Rindi","year":"1999","unstructured":"Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, Stolte M, Capella C, Bordi C, Solcia E (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116:532\u2013542. https:\/\/doi.org\/10.1016\/s0016-5085(99)70174-5","journal-title":"Gastroenterology"},{"key":"4340_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-024-00508-y","volume":"10","author":"G Lamberti","year":"2024","unstructured":"Lamberti G, Panzuto F, Pavel M, O\u2019Toole D, Ambrosini V, Falconi M, Garcia-Carbonero R, Riechelmann RP, Rindi G, Campana D (2024) Gastric neuroendocrine neoplasms. Nat Rev Dis Primers 10:25. https:\/\/doi.org\/10.1038\/s41572-024-00508-y","journal-title":"Nat Rev Dis Primers"},{"key":"4340_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/gastro\/gov004","volume":"3","author":"S Dacha","year":"2015","unstructured":"Dacha S, Razvi M, Massaad J, Cai Q, Wehbi M (2015) Hypergastrinemia. Gastroenterol Rep 3:201\u2013208. https:\/\/doi.org\/10.1093\/gastro\/gov004","journal-title":"Gastroenterol Rep"},{"key":"4340_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1245\/s10434-023-14712-9","volume":"31","author":"C Sok","year":"2024","unstructured":"Sok C, Ajay PS, Tsagkalidis V, Kooby DA, Shah MM (2024) Management of gastric neuroendocrine tumors: a review. Ann Surg Oncol 31:1509\u20131518. https:\/\/doi.org\/10.1245\/s10434-023-14712-9","journal-title":"Ann Surg Oncol"},{"key":"4340_CR38","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3390\/cancers15082202","volume":"15","author":"A Laffi","year":"2023","unstructured":"Laffi A, Lania AGA, Ragni A, Di Vito V, Liccardi A, Rubino M, Sesti F, Colao A, Faggiano A (2023) Gastric neuroendocrine tumors (G-NETs): a systematic review of the management and outcomes of type 3 G-NETs. Cancers (Basel) 15:2202. https:\/\/doi.org\/10.3390\/cancers15082202","journal-title":"Cancers (Basel)"},{"key":"4340_CR39","unstructured":"La Rosa S, Rindi G, Tang L, Solcia E (2019) Gastric neuroendocrine neoplasms. In: WHO Classification of Tumours Editorial Board. Digestive system tumours. 5th edn. International Agency for Research on Cancer, Lyon, pp 104\u2013109"},{"key":"4340_CR40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/den.13778","volume":"33","author":"T Hirasawa","year":"2021","unstructured":"Hirasawa T, Yamamoto N, Sano T (2021) Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study. Dig Endosc 33:408\u2013417. https:\/\/doi.org\/10.1111\/den.13778","journal-title":"Dig Endosc"},{"key":"4340_CR41","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.10901","volume":"105","author":"BH Min","year":"2018","unstructured":"Min BH, Hong M, Lee JH, Rhee PL, Sohn TS, Kim S, Kim KM, Kim JJ (2018) Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Br J Surg 105:1480\u20131486. https:\/\/doi.org\/10.1002\/bjs.10901","journal-title":"Br J Surg"},{"key":"4340_CR42","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.2217\/fon-2020-0150","volume":"16","author":"X Jiao","year":"2020","unstructured":"Jiao X, Wang Z, Peng X, Zhang L, Zhou L (2020) Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors. Future Oncol 16:2197\u20132207. https:\/\/doi.org\/10.2217\/fon-2020-0150","journal-title":"Future Oncol"},{"key":"4340_CR43","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.4251\/wjgo.v12.i12.1416","volume":"12","author":"YL Li","year":"2020","unstructured":"Li YL, Qiu XD, Chen J, Zhang Y, Li J, Xu JM, Wang C, Qi ZR, Luo J, Tan HY (2020) Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours. World J Gastrointest Oncol 12:1416\u20131427. https:\/\/doi.org\/10.4251\/wjgo.v12.i12.1416","journal-title":"World J Gastrointest Oncol"},{"key":"4340_CR44","doi-asserted-by":"publisher","unstructured":"Delle Fave G, O'Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, Ferone D, Ito T, Weber W, Zheng-Pei Z, De Herder WW, Pascher A, Ruszniewski P; Vienna Consensus Conference participants (2016) ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology 103:119-24. https:\/\/doi.org\/10.1159\/000443168","DOI":"10.1159\/000443168"},{"key":"4340_CR45","doi-asserted-by":"publisher","unstructured":"Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, Jensen RT; North American Neuroendocrine Tumor Society (NANETS) (2010) NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39:735-752. https:\/\/doi.org\/10.1097\/MPA.0b013e3181ebb168","DOI":"10.1097\/MPA.0b013e3181ebb168"},{"key":"4340_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12328-024-01969-0","volume":"17","author":"Y Sasaki","year":"2024","unstructured":"Sasaki Y, Abe Y, Haruma K, Sato H, Yagi M, Mizumoto N, Onozato Y, Ito M, Watabe T, Ueno Y (2024) Multiple gastric neuroendocrine tumors in a patient with parietal cell dysfunction and adenosine triphosphatase H+\/K+ transporting subunit alpha gene variant. Clin J Gastroenterol 17:607\u2013616. https:\/\/doi.org\/10.1007\/s12328-024-01969-0","journal-title":"Clin J Gastroenterol"},{"key":"4340_CR47","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1093\/hmg\/ddv054","volume":"24","author":"O Calvete","year":"2015","unstructured":"Calvete O, Reyes J, Zu\u00f1iga S, Paumard-Hern\u00e1ndez B, Fern\u00e1ndez V, Bujanda L, Rodriguez-Pinilla MS, Palacios J, Heine-Su\u00f1er D, Banka S, Newman WG, Ca\u00f1amero M, Pritchard DM, Ben\u00edtez J (2015) Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour. Hum Mol Genet 24:2914\u20132922. https:\/\/doi.org\/10.1093\/hmg\/ddv054","journal-title":"Hum Mol Genet"},{"key":"4340_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/apm.12546","volume":"124","author":"R Fossmark","year":"2016","unstructured":"Fossmark R, Calvete O, Mj\u00f8nes P, Benitez J, Waldum HL (2016) ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit. APMIS 124:561\u2013566. https:\/\/doi.org\/10.1111\/apm.12546","journal-title":"APMIS"},{"key":"4340_CR49","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3390\/cells10123500","volume":"10","author":"O Calvete","year":"2021","unstructured":"Calvete O, Reyes J, Vald\u00e9s-Socin H, Martin P, Marazuela M, Barroso A, Escalada J, Castells A, Torres-Ruiz R, Rodr\u00edguez-Perales S, Curr\u00e1s-Freixes M, Ben\u00edtez J (2021) Alterations in SLC4A2, SLC26A7 and SLC26A9 drive acid-base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario. Cells 10:3500. https:\/\/doi.org\/10.3390\/cells10123500","journal-title":"Cells"},{"key":"4340_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02739887","volume":"6","author":"A Ooi","year":"1995","unstructured":"Ooi A, Ota M, Katsuda S, Nakanishi I, Sugawara H, Takahashi I (1995) An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr Pathol 6:229\u2013237. https:\/\/doi.org\/10.1007\/BF02739887","journal-title":"Endocr Pathol"},{"key":"4340_CR51","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/01.pas.0000163363.86099.9f","volume":"29","author":"SC Abraham","year":"2005","unstructured":"Abraham SC, Carney JA, Ooi A, Choti MA, Argani P (2005) Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol 29:969\u2013975. https:\/\/doi.org\/10.1097\/01.pas.0000163363.86099.9f","journal-title":"Am J Surg Pathol"},{"key":"4340_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/a:1018881617038","volume":"43","author":"Y Haga","year":"1998","unstructured":"Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimura M, Ogawa M (1998) Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 43:253\u2013257. https:\/\/doi.org\/10.1023\/a:1018881617038","journal-title":"Dig Dis Sci"},{"key":"4340_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020662","volume":"21","author":"DM McCarthy","year":"2020","unstructured":"McCarthy DM (2020) Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids-what is the relationship? Int J Mol Sci 21:662. https:\/\/doi.org\/10.3390\/ijms21020662","journal-title":"Int J Mol Sci"},{"key":"4340_CR54","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/his.14220","volume":"77","author":"VQ Trinh","year":"2020","unstructured":"Trinh VQ, Shi C, Ma C (2020) Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis. Histopathology 77:865\u2013876. https:\/\/doi.org\/10.1111\/his.14220","journal-title":"Histopathology"},{"key":"4340_CR55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5858\/arpa.2020-0315-OA","volume":"146","author":"R Rais","year":"2022","unstructured":"Rais R, Trikalinos NA, Liu J, Chatterjee D (2022) Enterochromaffin-like cell hyperplasia-associated gastric neuroendocrine tumors may arise in the setting of proton pump inhibitor use. Arch Pathol Lab Med 146:366\u2013371. https:\/\/doi.org\/10.5858\/arpa.2020-0315-OA","journal-title":"Arch Pathol Lab Med"},{"key":"4340_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/ajcp\/aqad021","volume":"160","author":"K Logan","year":"2023","unstructured":"Logan K, Shi C (2023) Clinicopathologic features of non-type 1\/2 gastric neuroendocrine tumors and their associated mucosal changes. Am J Clin Pathol 160:130\u2013136. https:\/\/doi.org\/10.1093\/ajcp\/aqad021","journal-title":"Am J Clin Pathol"},{"key":"4340_CR57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12029-011-9275-z","volume":"43","author":"E Latta","year":"2012","unstructured":"Latta E, Rotondo F, Leiter LA, Horvath E, Kovacs K (2012) Ghrelin- and serotonin-producing gastric carcinoid. J Gastrointest Cancer 43:319\u2013323. https:\/\/doi.org\/10.1007\/s12029-011-9275-z","journal-title":"J Gastrointest Cancer"},{"key":"4340_CR58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.17235\/reed.2024.10364\/2024","volume":"117","author":"LM Relvas","year":"2025","unstructured":"Relvas LM, Gago T, Velasco F, Barros S, Carvalho I, Peixe B (2025) Gastric neuroendocrine tumor presenting with carcinoid syndrome. Rev Esp Enferm Dig 117:281\u2013282. https:\/\/doi.org\/10.17235\/reed.2024.10364\/2024","journal-title":"Rev Esp Enferm Dig"},{"key":"4340_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3748\/wjg.v27.i1.129","volume":"27","author":"T Okamoto","year":"2021","unstructured":"Okamoto T, Yoshimoto T, Ohike N, Fujikawa A, Kanie T, Fukuda K (2021) Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: a case report and review of literature. World J Gastroenterol 27:129\u2013142. https:\/\/doi.org\/10.3748\/wjg.v27.i1.129","journal-title":"World J Gastroenterol"},{"key":"4340_CR60","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5946\/ce.2013.46.5.582","volume":"46","author":"V Prachayakul","year":"2013","unstructured":"Prachayakul V, Aswakul P, Deesomsak M, Pongpaibul A (2013) Gastric somatostatinoma: an extremely rare cause of upper gastrointestinal bleeding. Clin Endosc 46:582\u2013585. https:\/\/doi.org\/10.5946\/ce.2013.46.5.582","journal-title":"Clin Endosc"},{"key":"4340_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000445165","volume":"104","author":"M Milione","year":"2017","unstructured":"Milione M, Maisonneuve P, Spada F, Pellegrinelli A, Spaggiari P, Albarello L, Pisa E, Barberis M, Vanoli A, Buzzoni R, Pusceddu S, Concas L, Sessa F, Solcia E, Capella C, Fazio N, La Rosa S (2017) The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories. Neuroendocrinology 104:85\u201393. https:\/\/doi.org\/10.1159\/000445165","journal-title":"Neuroendocrinology"},{"issue":"Suppl 1","key":"4340_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5146\/tjpath.2015.01319","volume":"31","author":"S Uccella","year":"2015","unstructured":"Uccella S, Sessa F, La Rosa S (2015) Diagnostic approach to neuroendocrine neoplasms of the gastrointestinal tract and pancreas. Turk Patoloji Derg 31(Suppl 1):113\u2013127. https:\/\/doi.org\/10.5146\/tjpath.2015.01319","journal-title":"Turk Patoloji Derg"},{"key":"4340_CR63","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12022-018-9522-y","volume":"29","author":"S Uccella","year":"2018","unstructured":"Uccella S, La Rosa S, Volante M, Papotti M (2018) Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol 29:150\u2013168. https:\/\/doi.org\/10.1007\/s12022-018-9522-y","journal-title":"Endocr Pathol"},{"key":"4340_CR64","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12672-025-02576-2","volume":"16","author":"S Kim","year":"2025","unstructured":"Kim S, Seo J, Shin Y, Kim M (2025) Expression of insulinoma-associated protein 1 (INSM1) in gastric neuroendocrine and non-neuroendocrine neoplasms. Discov Oncol 16:754. https:\/\/doi.org\/10.1007\/s12672-025-02576-2","journal-title":"Discov Oncol"},{"key":"4340_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12022-024-09807-2","volume":"35","author":"S Uccella","year":"2024","unstructured":"Uccella S (2024) Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that? Endocr Pathol 35:91\u2013106. https:\/\/doi.org\/10.1007\/s12022-024-09807-2","journal-title":"Endocr Pathol"},{"key":"4340_CR66","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00428-024-04006-0","volume":"486","author":"C Kanaan","year":"2025","unstructured":"Kanaan C, Bani MA, Ducreux M, Planchard D, Lamartina L, Moog S, Pudlarz T, Baudin E, Hadoux J, Al-Ghuzlan A, Scoazec JY (2025) Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms. Virchows Arch 486:941\u2013950. https:\/\/doi.org\/10.1007\/s00428-024-04006-0","journal-title":"Virchows Arch"},{"key":"4340_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/ERC-14-0410","volume":"22","author":"N Sahnane","year":"2015","unstructured":"Sahnane N, Furlan D, Monti M, Romualdi C, Vanoli A, Vicari E, Solcia E, Capella C, Sessa F, La Rosa S (2015) Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocr Relat Cancer 22:35\u201345. https:\/\/doi.org\/10.1530\/ERC-14-0410","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"4340_CR68","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1530\/ERC-17-0557","volume":"25","author":"M Milione","year":"2018","unstructured":"Milione M, Maisonneuve P, Pellegrinelli A, Grillo F, Albarello L, Spaggiari P, Vanoli A, Tagliabue G, Pisa E, Messerini L, Centonze G, Inzani F, Scarpa A, Papotti M, Volante M, Sessa F, Fazio N, Pruneri G, Rindi G, Solcia E, La Rosa S, Capella C (2018) Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis. Endocr Relat Cancer 25(5):583\u2013593. https:\/\/doi.org\/10.1530\/ERC-17-0557","journal-title":"Endocr Relat Cancer"},{"key":"4340_CR69","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00428-024-03825-5","volume":"485","author":"E Multone","year":"2024","unstructured":"Multone E, La Rosa S, Sempoux C, Uccella S (2024) PD-L1 expression, tumor-infiltrating lymphocytes, and mismatch repair proteins status in digestive neuroendocrine neoplasms: exploring their potential role as theragnostic and prognostic biomarkers. Virchows Arch 485:841\u2013851. https:\/\/doi.org\/10.1007\/s00428-024-03825-5","journal-title":"Virchows Arch"},{"key":"4340_CR70","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12885-025-13953-z","volume":"25","author":"K Zhou","year":"2025","unstructured":"Zhou K, Hu X, Yang X, Wu Y, Ji K, Ji X, Zhang J, Wu X, Li Z, Wang A, Wang Y, Bu Z (2025) Clinicopathologic characteristics and prognostic factors of pure gastric neuroendocrine carcinoma patients undergoing radical surgery. BMC Cancer 25:606. https:\/\/doi.org\/10.1186\/s12885-025-13953-z","journal-title":"BMC Cancer"},{"key":"4340_CR71","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.humpath.2014.01.019","volume":"45","author":"C Capella","year":"2014","unstructured":"Capella C, Marando A, Longhi E, Bernasconi B, Finzi G, Parravicini C, Sessa F, La Rosa S (2014) Primary gastric Merkel cell carcinoma harboring DNA polyomavirus: first description of an unusual high-grade neuroendocrine carcinoma. Hum Pathol 45:1310\u20131314. https:\/\/doi.org\/10.1016\/j.humpath.2014.01.019","journal-title":"Hum Pathol"},{"key":"4340_CR72","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/his.14178","volume":"77","author":"S Uccella","year":"2020","unstructured":"Uccella S, La Rosa S (2020) Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology 77:700\u2013717. https:\/\/doi.org\/10.1111\/his.14178","journal-title":"Histopathology"},{"key":"4340_CR73","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","volume":"27","author":"S La Rosa","year":"2016","unstructured":"La Rosa S, Sessa F, Uccella S (2016) Mixed neuroendocrine-nonneuroendocrine neoplasms (minens): unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol 27:284\u2013311. https:\/\/doi.org\/10.1007\/s12022-016-9432-9","journal-title":"Endocr Pathol"},{"key":"4340_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cancers4010011","volume":"4","author":"S La Rosa","year":"2012","unstructured":"La Rosa S, Marando A, Sessa F, Capella C (2012) Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update. Cancers (Basel) 4:11\u201330. https:\/\/doi.org\/10.3390\/cancers4010011","journal-title":"Cancers (Basel)"},{"key":"4340_CR75","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/PAS.0000000000001123","volume":"42","author":"S La Rosa","year":"2018","unstructured":"La Rosa S, Uccella S, Molinari F, Savio A, Mete O, Vanoli A, Maragliano R, Frattini M, Mazzucchelli L, Sessa F, Bongiovanni M (2018) Mixed adenoma well-differentiated neuroendocrine tumor (MANET) of the digestive system: an indolent subtype of mixed neuroendocrine-nonneuroendocrine neoplasm (MiNEN). Am J Surg Pathol 42:1503\u20131512. https:\/\/doi.org\/10.1097\/PAS.0000000000001123","journal-title":"Am J Surg Pathol"},{"key":"4340_CR76","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00428-024-03851-3","volume":"486","author":"H Rokutan","year":"2025","unstructured":"Rokutan H, Fukasawa-Hokazono M, Hokazono Y, Ushiku T (2025) Mixed adenoma-neuroendocrine tumor of the stomach: analysis of nine cases with literature review. Virchows Arch 486:521\u2013530. https:\/\/doi.org\/10.1007\/s00428-024-03851-3","journal-title":"Virchows Arch"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04340-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:53:53Z","timestamp":1770274433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04340-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04340-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is a review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"SLR is a member of the Editorial Board of Virchows Archiv. SU declares no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}